ClinicalTrials.Veeva

Menu

Automatic Detection of Dyspnea in Mechanically Ventilated, Critically Ill Patients

H

Hospital de Clinicas José de San Martín

Status

Enrolling

Conditions

Dyspnea During Mechanical Ventilation

Study type

Observational

Funder types

Other

Identifiers

NCT07205952
1337-25

Details and patient eligibility

About

The investigators will conduct a prospective, observational, two-center ICU study of 60 subjects on mechanical ventilation with respiratory failure of any cause.

Full description

Inclusion criteria:

  • Adults of either sex (≥18 years)
  • Non-c0mmunicative, endotracheally intubated in the past 24 hours.
  • Expected to require ≥24 hours of mechanical ventilation.

Exclusion criteria:

  • Continuous neuromuscular blockade.
  • Ventilated on Airway Pressure Release Ventilation mode.

Ventilator measured airway pressure and flow signals will be streamed at 31.25 Hz into 131.1-s time windows (epochs) for up to 5 days. A recursive algorithm will compute individual breath's inspiratory effort (Pmus) and calculate the inspiratory effort time-pressure product (PmusPTP cmH₂O·s·min-¹).

Trained staff will assess the Mechanical Ventilation-Respiratory Distress Observation Scale (MV-RDOS), an intermittent and subjective assessment of dyspnea, at least twice daily. These will be time-matched to the airway signal epochs to determine their degree of correlation by Pearsons R2.

Using receiver operating characteristic (ROC) area under the curve (AUC) analysis, the investigators will determine a dyspnea threshold for PmusPTP equivalent to the dyspnea cut-off for MV-RDOS > 2.6, and report sensitivity/specificity.

To address possible label misclassification, the investigators will train six supervised classifiers on concordant data pairs and apply a unanimity ensemble to label discordant pairs as "dyspneic", not dyspneic" and undetermined". Ensemble determined labels conflicting with those classified by MV-RDOS will be excluded from a secondary analysis.

Primary outcome will be Pearson's R2 (PmusPTP vs MV-RDOS). Secondary outcome will be 28-day ventilator-free days.

Enrollment

60 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults of either sex (≥18 years)
  • Endotracheally intubated in the past 24 hours.
  • Expected to require ≥24 hours of mechanical ventilation.

Exclusion criteria

  • Continuous neuromuscular blockade.
  • Ventilated on Airway Pressure Release Ventilation mode.

Trial design

60 participants in 1 patient group

Adults on invasive mechanical ventilation
Description:
Adults of either gender on invasive mechanical ventilation within the preceding 24 hours; and an anticipated need for continued ventilation for ≥24 additional hours. Exclusion criteria are continuous neuromuscular blockade at the time of screening and ventilation using airway pressure release ventilation (APRV).

Trial contacts and locations

1

Loading...

Central trial contact

Guillermo Gutierrez, MD, PhD; Celica Irrazabal, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems